The 2010 edition of China Pharmacopoeia has been compiled and will be published by China Medical Science and Technology Publishing House. It will be officially implemented on July 1 this year. The Chinese pharmacopoeia is a drug code formulated by the state to ensure the quality of drugs and ensure the safety and effectiveness of drug use by the people. It is the legal basis for the strict compliance of the drug development, production, operation, use and management. It is the core of the national drug standard system and an important part of international exchange and cooperation. Yes. The 2010 edition of China pharmacopoeia is the ninth edition of Pharmacopoeia organized by new China for 60 years. On the basis of the summary of the Pharmacopoeia, the new edition of Pharmacopoeia makes full use of the domestic and foreign drug standard resources in recent years, pays more attention to innovation and development, and reflects the current situation of the development of the pharmaceutical industry and the clinical medication level in our country. It provides a strong technical support for further strengthening drug supervision and management. The 2010 edition of the Chinese pharmacopoeia is divided into three parts: one is Chinese traditional medicine, the other two is chemical medicine, and the three is biological products. In the 2010 edition of the Chinese Pharmacopoeia, more than 4600 varieties were collected, of which more than 1300 were added, which basically covered the varieties of the national basic drugs catalogue and the national medical insurance catalogue.